Screening differentially expressed genes between endometriosis and ovarian cancer to find new biomarkers for endometriosis

References

• Wang Y, Nicholes K, Shih IM. The origin and pathogenesis of endometriosis. Annu Rev Pathol. 2020;15:71–95.
   PubMed Web of Science ®Google Scholar
• Ng SW, Norwitz SG, Taylor HS, et al. Endometriosis: the role of iron overload and ferroptosis. Reprod Sci. 2020;27(7):1383–1390.
   PubMed Web of Science ®Google Scholar
• Vallee A, Lecarpentier Y. Curcumin and endometriosis. Int J Mol Sci. 2020;21;2440.
   PubMed Web of Science ®Google Scholar
• Reis FM, Coutinho LM, Vannuccini S, et al. Is stress a cause or a consequence of endometriosis? Reprod Sci. 2020;27(1):39–45.
   PubMed Web of Science ®Google Scholar
• Prins JR, Marissen LM, Scherjon SA, et al. Is there an immune modulating role for follicular fluid in endometriosis? A narrative review. Reproduction. 2020;159(1):R45–R54.
   PubMed Web of Science ®Google Scholar
• Schwartz K, Llarena NC, Rehmer JM, et al. The role of pharmacotherapy in the treatment of endometriosis across the lifespan. Expert Opin Pharmacother. 2020;21(8):893–903.
   PubMed Web of Science ®Google Scholar
• Barani M, Bilal M, Sabir F, et al. Nanotechnology in ovarian cancer: diagnosis and treatment. Life Sci. 2021;266:118914.
   PubMed Web of Science ®Google Scholar
• Anglesio MS, Yong PJ. Endometriosis-associated ovarian cancers. Clinical Obstetrics and Gynecology. 2017;60:711–727.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Sumimoto K, Moniwa N, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007;17(1):37–43.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Sakoda LC, Sherman ME, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2929–2935.
   PubMed Web of Science ®Google Scholar
• Yachida N, Yoshihara K, Yamaguchi M, et al. How does endometriosis lead to ovarian cancer? The molecular mechanism of endometriosis-associated ovarian cancer development. Cancers. 2021;13:1439.
   PubMed Web of Science ®Google Scholar
• Gaia-Oltean AI, Braicu C, Gulei D, et al. Ovarian endometriosis, a precursor of ovarian cancer: histological aspects, gene expression and microRNA alterations (review). Exp Ther Med. 2021;21(3):243.
   PubMed Web of Science ®Google Scholar
• Murakami K, Kotani Y, Shiro R, et al. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts. Int J Clin Oncol. 2020;25(1):51–58.
   PubMed Web of Science ®Google Scholar
• Oda K, Hamanishi J, Matsuo K, et al. Genomics to immunotherapy of ovarian clear cell carcinoma: unique opportunities for management. Gynecol Oncol. 2018;151(2):381–389.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Vigano P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.
   PubMed Web of Science ®Google Scholar
• Gerhold DL, Jensen RV, Gullans SR. Better therapeutics through microarrays. Nat Genet. 2002;32(Suppl.):547–551.
   PubMed Web of Science ®Google Scholar
• Cheung VG, Spielman RS. The genetics of variation in gene expression. Nat Genet. 2002;32(Suppl.):522–525.
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Thirumal Kumar D, Bithia R, et al. Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: a systematic and bioinformatics approach. Front Genet. 2020;11:734.
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Bithia R, Thirumal Kumar D, et al. Involvement of essential signaling cascades and analysis of gene networks in diabesity. Genes. 2020;11:25.
   Web of Science ®Google Scholar
• Fu D, Zhang B, Yang L, et al. Development of an immune-related risk signature for predicting prognosis in lung squamous cell carcinoma. Front Genet. 2020;11:978.
   PubMed Web of Science ®Google Scholar
• Wan J, Jiang S, Jiang Y, et al. Data mining and expression analysis of differential lncRNA ADAMTS9-AS1 in prostate cancer. Front Genet. 2019;10:1377.
   PubMed Web of Science ®Google Scholar
• Zeng X, Yue Z, Gao Y, et al. NR4A1 is involved in fibrogenesis in ovarian endometriosis. Cell Physiol Biochem. 2018;46(3):1078–1090.
   PubMedGoogle Scholar
• Yin M, Zhang J, Zeng X, et al. Target identification and drug discovery by data-driven hypothesis and experimental validation in ovarian endometriosis. Fertil Steril. 2021;116(2):478–492.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou Y, Xu H, et al. Bioinformatic analysis reveals the importance of epithelial-mesenchymal transition in the development of endometriosis. Sci Rep. 2020;10(1):8442.
   PubMed Web of Science ®Google Scholar
• Dai FF, Bao AY, Luo B, et al. Identification of differentially expressed genes and signaling pathways involved in endometriosis by integrated bioinformatics analysis. Exp Ther Med. 2019;19:264–272.
   PubMed Web of Science ®Google Scholar
• Hu W, Xie Q, Xu Y, et al. Integrated bioinformatics analysis reveals function and regulatory network of miR-200b-3p in endometriosis. Biomed Res Int. 2020;2020:3962953.
   PubMed Web of Science ®Google Scholar
• Khalaj K, Miller JE, Lingegowda H, et al. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight. 2019;4:e128846.
   PubMed Web of Science ®Google Scholar
• Wang D, Luo Y, Wang G, et al. Circular RNA expression profiles and bioinformatics analysis in ovarian endometriosis. Mol Genet Genomic Med. 2019;7(7):e00756.
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41(Database issue):D991–D995.
   PubMed Web of Science ®Google Scholar
• Lou W, Ding B, Xu L, et al. Construction of potential glioblastoma multiforme-related miRNA-mRNA regulatory network. Front Mol Neurosci. 2019;12:66.
   PubMed Web of Science ®Google Scholar
• Li MX, Jin LT, Wang TJ, et al. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis. Onco Targets Ther. 2018;11:4105–4112.
   PubMed Web of Science ®Google Scholar
• The Gene Ontology Consortium. The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330–D338.
   PubMed Web of Science ®Google Scholar
• Thomas PD, Hill DP, Mi H, et al. Gene ontology causal activity modeling (GO-CAM) moves beyond GO annotations to structured descriptions of biological functions and systems. Nat Genet. 2019;51(10):1429–1433.
   PubMed Web of Science ®Google Scholar
• Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation. Genome Biol. 2003;4(9):P3.
   PubMed Web of Science ®Google Scholar
• Zhao L, Fu X, Han X, et al. Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma. Cancer Cell Int. 2021;21(1):80.
   PubMed Web of Science ®Google Scholar
• Rabbani G, Baig MH, Ahmad K, et al. Protein–protein interactions and their role in various diseases and their prediction techniques. Curr Protein Pept Sci. 2018;19(10):948–957.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Griffith M, Griffith OL, Coffman AC, et al. DGIdb: mining the druggable genome. Nat Methods. 2013;10(12):1209–1210.
   PubMed Web of Science ®Google Scholar
• Rudnicka L, Varga J, Christiano AM, et al. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest. 1994;93(4):1709–1715.
   PubMed Web of Science ®Google Scholar
• Ryynanen M, Ryynanen J, Sollberg S, et al. Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J Clin Invest. 1992;89(3):974–980.
   PubMed Web of Science ®Google Scholar
• Zondervan KT, Becker CM, Koga K, et al. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9.
   PubMed Web of Science ®Google Scholar
• Mizutani S, Matsumoto K, Kato Y, et al. New insights into human endometrial aminopeptidases in both implantation and menstruation. Biochim Biophys Acta Proteins Proteom. 2020;1868(2):140332.
   PubMed Web of Science ®Google Scholar
• Montgomery GW, Mortlock S, Giudice LC. Should genetics now be considered the pre-eminent etiologic factor in endometriosis? J Minim Invasive Gynecol. 2020;27(2):280–286.
   PubMed Web of Science ®Google Scholar
• Pearce CL, Stram DO, Ness RB, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015;24(4):671–676.
   PubMed Web of Science ®Google Scholar
• Munksgaard PS, Blaakaer J. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol. 2012;124(1):164–169.
   PubMed Web of Science ®Google Scholar
• Eyster KM, Klinkova O, Kennedy V, et al. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril. 2007;88(6):1505–1533.
   PubMed Web of Science ®Google Scholar
• Yu W, Li D, Zhang Y, et al. MiR-142-5p acts as a significant regulator through promoting proliferation, invasion, and migration in breast cancer modulated by targeting SORBS1. Technol Cancer Res Treat. 2019;18:1533033819892264.
   Web of Science ®Google Scholar
• Bhandari A, Xia E, Zhou Y, et al. ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer. Cancer Manag Res. 2018;10:969–976.
   PubMed Web of Science ®Google Scholar
• Huang W, Yu D, Wang M, et al. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Cell Prolif. 2020;53(7):e12836.
   PubMed Web of Science ®Google Scholar
• Li W, Li S, Yang J, et al. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer. Onco Targets Ther. 2019;12:3753–3763.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang D, Li X, et al. Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through wnt/PCP signaling and FAK/SRC pathway. Biomed Pharmacother. 2016;81:145–151.
   PubMed Web of Science ®Google Scholar
• Ge JC, Wang YX, Chen ZB, et al. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma. Cell Signal. 2020;66:109465.
   PubMed Web of Science ®Google Scholar
• Liao HD, Mao Y, Ying YG. The involvement of the laminin-integrin alpha7beta1 signaling pathway in mechanical ventilation-induced pulmonary fibrosis. J Thorac Dis. 2017;9(10):3961–3972.
   PubMed Web of Science ®Google Scholar
• Song J, Yang P, Lu J. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer. Cancer Biomark. 2020;27(1):51–61.
   PubMed Web of Science ®Google Scholar
• Ji Q, Zhou L, Sui H, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation. Nat Commun. 2020;11(1):1211.
   PubMed Web of Science ®Google Scholar
• Cho WC, Jang JE, Kim KH, et al. SORBS1 serves a metastatic role via suppression of AHNAK in colorectal cancer cell lines. Int J Oncol. 2020;56(5):1140–1151.
   PubMed Web of Science ®Google Scholar
• Song L, Chang R, Dai C, et al. SORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drug. Oncotarget. 2017;8(6):9108–9122.
   PubMedGoogle Scholar
• Qi F, Qin WX, Zang YS. Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathways. Oncol Lett. 2019;17(3):2905–2914.
   PubMed Web of Science ®Google Scholar
• Hsu HM, Chu CM, Chang YJ, et al. Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. Sci Rep. 2019;9(1):4484.
   PubMed Web of Science ®Google Scholar
• Yeong J, Lim JCT, Lee B, et al. High densities of tumor-associated plasma cells predict improved prognosis in triple negative breast cancer. Front Immunol. 2018;9:1209.
   PubMed Web of Science ®Google Scholar
• Rolim I, Duarte N, Barata G, et al. Immunoglobulin M gene association with autoantibody reactivity and type 1 diabetes. Immunogenetics. 2017;69(7):429–437.
   PubMed Web of Science ®Google Scholar
• Ceballos-Francisco D, Cordero H, Guardiola FA, et al. Healing and mucosal immunity in the skin of experimentally wounded gilthead seabream (Sparus aurata L). Fish Shellfish Immunol. 2017;71:210–219.
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Saleem A, Thirumal Kumar D, et al. A systemic approach to explore the mechanisms of drug resistance and altered signaling cascades in extensively drug-resistant tuberculosis. Adv Protein Chem Struct Biol. 2021;127:343–364.
   PubMed Web of Science ®Google Scholar
• Mishra S, Shah MI, Udhaya Kumar S, et al. Network analysis of transcriptomics data for the prediction and prioritization of membrane-associated biomarkers for idiopathic pulmonary fibrosis (IPF) by bioinformatics approach. Adv Protein Chem Struct Biol. 2021;123:241–273.
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Thirumal Kumar D, Siva R, et al. Dysregulation of signaling pathways due to differentially expressed genes from the B-cell transcriptomes of systemic lupus erythematosus patients – a bioinformatics approach. Front Bioeng Biotechnol. 2020;8:276.
   PubMed Web of Science ®Google Scholar
• Yan H, Zheng G, Qu J, et al. Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. J Cell Physiol. 2019;234(12):23785–23797.
   PubMed Web of Science ®Google Scholar
• Kumar SU, Kumar DT, Siva R, et al. Integrative bioinformatics approaches to map potential novel genes and pathways involved in ovarian cancer. Front Bioeng Biotechnol. 2019;7:391.
   PubMed Web of Science ®Google Scholar
• Wang B, Yin X, Gan W, et al. PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma. Autophagy. 2020;1–19.
   Google Scholar
• Gutierrez Olivares VM, Gonzalez Torres LM, Hunter Cuartas G, et al. Immunohistochemical profile of renal cell tumours. Rev Esp Patol. 2019;52(4):214–221.
   PubMedGoogle Scholar
• Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic. 2008;9(6):871–881.
   PubMed Web of Science ®Google Scholar
• Zhou W, Lian Y, Jiang J, et al. Differential expression of microRNA in exosomes derived from endometrial stromal cells of women with endometriosis-associated infertility. Reprod Biomed Online. 2020;41(2):170–181.
   PubMed Web of Science ®Google Scholar
• Wu J, Huang H, Huang W, et al. Analysis of exosomal lncRNA, miRNA and mRNA expression profiles and ceRNA network construction in endometriosis. Epigenomics. 2020;12(14):1193–1213.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zha J, Zuo M, et al. Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer. J Cell Biochem. 2020;121(3):2655–2663.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang L, Yu Q, et al. The estrogen-regulated lncRNA H19/miR-216a-5p axis alters stromal cell invasion and migration via ACTA2 in endometriosis. Mol Hum Reprod. 2019;25(9):550–561.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu L, Zhong Y, et al. LncRNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through miR-342-3p/IER3 pathway. Cell Biosci. 2019;9:84.
   PubMed Web of Science ®Google Scholar